ArticleBone marrow transplantation2023

Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan.

Mizuki Haraguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.